KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Shares Outstanding (Weighted Average): 2014-2024

Historic Shares Outstanding (Weighted Average) for BeOne Medicines (ONC) over the last 11 years, with Dec 2024 value amounting to $1.4 billion.

  • BeOne Medicines' Shares Outstanding (Weighted Average) rose 3.69% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year change of. This contributed to the annual value of $1.4 billion for FY2024, which is 1.95% up from last year.
  • Latest data reveals that BeOne Medicines reported Shares Outstanding (Weighted Average) of $1.4 billion as of FY2024, which was up 1.95% from $1.4 billion recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Shares Outstanding (Weighted Average) registered a high of $1.4 billion during FY2024, and its lowest value of $1.2 billion during FY2020.
  • In the last 3 years, BeOne Medicines' Shares Outstanding (Weighted Average) had a median value of $1.4 billion in 2023 and averaged $1.4 billion.
  • Data for BeOne Medicines' Shares Outstanding (Weighted Average) shows a peak YoY surged of 50.05% (in 2020) over the last 5 years.
  • Over the past 5 years, BeOne Medicines' Shares Outstanding (Weighted Average) (Yearly) stood at $1.2 billion in 2020, then increased by 3.11% to $1.2 billion in 2021, then increased by 10.65% to $1.3 billion in 2022, then climbed by 0.73% to $1.4 billion in 2023, then grew by 1.95% to $1.4 billion in 2024.